| Sam Sheng Shay, MD | |
|
3700 California St, San Francisco, CA 94118-1618 | |
| (415) 719-0000 | |
| Not Available |
| Full Name | Sam Sheng Shay |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 3700 California St, San Francisco, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013958362 | NPI | - | NPPES |
| 00G437030 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | G43703 (California) | Primary |
| Entity Name | John Muir Trauma Physicians Billing Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093864837 PECOS PAC ID: 3476542515 Enrollment ID: O20050420001452 |
News Archive
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod.
Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.
Researchers at the University Medical Center of Johannes Gutenberg University Mainz and the German Research Center for Environmental Health, Helmholtz Zentrum München have discovered that too much of the oncogene Bcl-3 leads to chronic intestinal diseases.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
› Verified 8 days ago
| Entity Name | Pontine Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053757609 PECOS PAC ID: 1052550266 Enrollment ID: O20130722000133 |
News Archive
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod.
Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.
Researchers at the University Medical Center of Johannes Gutenberg University Mainz and the German Research Center for Environmental Health, Helmholtz Zentrum München have discovered that too much of the oncogene Bcl-3 leads to chronic intestinal diseases.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
› Verified 8 days ago
| Entity Name | Cep America - Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790401438 PECOS PAC ID: 3678897915 Enrollment ID: O20150115001110 |
News Archive
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod.
Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.
Researchers at the University Medical Center of Johannes Gutenberg University Mainz and the German Research Center for Environmental Health, Helmholtz Zentrum München have discovered that too much of the oncogene Bcl-3 leads to chronic intestinal diseases.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sam Sheng Shay, MD Po Box 39000, Dept 33995, San Francisco, CA 94139-0001 Ph: (503) 372-2740 | Sam Sheng Shay, MD 3700 California St, San Francisco, CA 94118-1618 Ph: (415) 719-0000 |
News Archive
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod.
Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.
Researchers at the University Medical Center of Johannes Gutenberg University Mainz and the German Research Center for Environmental Health, Helmholtz Zentrum München have discovered that too much of the oncogene Bcl-3 leads to chronic intestinal diseases.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
› Verified 8 days ago
Dr. Taylor Bergh Bucyk, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave # 3c38, San Francisco, CA 94110 Phone: 628-206-8000 | |
Dr. Celine Marie Madeleine Gonzalez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1305 Waller St, San Francisco, CA 94117 Phone: 415-640-9777 | |
David Howard Irwin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-719-0000 | |
Steven Gary Vitcov, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-719-0000 | |
Merlin D Larson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1600 Divisadero St, San Francisco, CA 94143 Phone: 415-885-7412 Fax: 415-885-7284 | |
Chris Abrecht, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2351 Clay St, Suite 380, San Francisco, CA 94115 Phone: 415-600-3954 |